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1. Introduction 
Numerous investigations of the in vitro phospho- 
rylation of skeletal muscle glycogen synthase have 
shown that the enzyme can be controlled by at least 
3 types of protein kinases and has approximately 6 
phosphorylation sites/subunit [l-3]. However, inves- 
tigations in to the in vivo phosphorylation state of gly- 
cogen synthase have begun only recently 13-61. Muscle 
glycogen synthase has been shown to be substantially 
phosphorylated (-3 mol phosphate/m01 subunit) 
under control conditions in vivo and in perfused hind- 
limb preparations [3,5,6]. Epinephrine and diabetes 
both increase the phosphorylation state, consistent 
with their effects on the activity properties of the 
enzyme [3,5,6]. 
Various studies have shown that insulin activates 
glycogen synthase in skeletal muscle [7-91. The effect 
of the hormone is characterized by an increase in the 
-glucose-6-P/+glucose-6-P activity and by a decrease 
in the Ae.a for glucose-6-P. In [4] insulin administra- 
tion to two rabbits resulted in a reduction of the 
phosphate content of the enzyme from 1.33-0.87 
mol/mol subunit. However, this result may be ques- 
tioned on account of the small number of animals 
involved and the low phosphate values reported. Using 
the rat hindlimb perfusion system we have further 
investigated the effects of insulin treatment on puri- 
fied glycogen synthase and have found a reduction in 
the chemical phosphate content consistent with the 
changes in the kinetic parameters of the enzyme. 
was modified from that in [5]. Rat hindlimbs were 
perfused for 20 min as in [lo], then for an additional 
30 min with either saline or insulin (1 mu/ml). At the 
end of the perfusion period, the muscle was freeze- 
clamped at liquid nitrogen temperature. The frozen 
tissue from 6-8 rats (-80 g) was homogenized in 5 
vol. buffer at 4°C containing 100 mM NaF, 10 mM 
EDTA, 1 mM dithiothreitol and 2 yg leupeptimml, at 
pH 7 .O. Acid precipitation was performed at pH 5.5. 
The first glycogen pellet was resuspended and centri- 
fuged at 4000 X g before application to a con A- 
Sepharose 4B column pre-equilibrated with 50 mM 
Tris, 50 mM NaF, 1 mM MgCla, 1 mM CaClz, 1 mM 
MnC12, 0.5 M NaCl and 1 mM dithiothreitol, at pH 
7.5. The column was then washed extensively (~10 
vol.) with 50 mM Tris, 50 mM NaF, 5 mM EDTA and 
1 mM dithiothreitol, at pH 7.5 (buffer A) containing 
0.5 M NaCl and 2 pg leupeptin/ml. Glycogen synthase 
was eluted with buffer A containing 200 mM glucose. 
Glycogen synthase activity was pooled, dialyzed over- 
night against buffer A containing 20% glycerol, then 
applied to a DEAE-Sepharose column. The column 
was washed extensively with buffer A containing 20% 
glycerol and 50 mM NaCl. Glycogen synthase was 
eluted with 250 mM NaCl, dialyzed against buffer A 
containing 50% glycerol and stored at -7O’C. 
Glycogen synthase was assayed essentially as in 
[ll]. Before assay, the enzyme was diluted in 50 mM 
Tris, 50 mM NaF, 5 mM EDTA, 1 mM dithiothreitol, 
1% glycogen and 1 mg bovine serum albumin/ml, at 
pH 7.8. Ao.S-Values for glycogen synthase activity in 
the extract were determined after filtration through 
Sephadex G-25 (1.5 X 25 cm). 
2. Methods 
The method for glycogen synthase purification 
Protein was determined by the method in [ 121 
and alkali-labile phosphate by the malachite-green 
technique [ 131. SDS-Polyacrylamide gel electroplio- 
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resis was performed as in [ using a Tris/glycine 
buffer system (pH 8.2). 
3. Results 
The changes in the purification scheme for gly- 
cogen synthase from [5] result in an apparently 
homogenous enzyme as determined by SDS-poly- 
acrylamide gel electrophoresis (fig.1). The minor con- 
taminant of Mr - 40 000 observed in [5,15] is not evi- 
dent under these conditions. Furthermore, the possi- 
bility of changes in the phosphorylation state during 
purification has been further minimized because the 
new procedure eliminates the amylase digestion of 
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Fig.1. Densitometric tracings of purified enzyme preparations. * The difference seen in specific activities for the final enzyme 
SDS-Polyacrylamide gel electrophoresis (7.5%) was per- preparations is probably not a result of the insulin treatment 
formed using glycogen synthase purified from control (A) since the activities are comparable in the extract for the 2 
and insulin-treated (B) muscle. After staining with Coomassie treatments, and the other 2 enzyme preparations used in 
blue, scanning was done at 580 nm using an ISCO model these studies had similar activities (13.4 units/mg for con- 
1310 gel scanner. Arrows indicate position of tracking dye. trol and 13.0 units/mg for insulin treated) 
glycogen and thus avoids exposure of the enzyme to 
elevated temperatures for extended periods. Also, the 
enzyme is no longer exposed to metal ions (Mn’+, 
Mg2+, Ca’+) during washing of con A-Sepharose. This 
is important, since the presence of free manganese has 
been found to activate phosphorylase phosphatase 
even in the presence of 50 mM NaF (unpublished). 
The new glycogen synthase preparations contained 
little or no activities of phosphorylase (<O.l pm01 . 
min-’ mg-r , measured in the presence of 1 n&l AMP), 
histone kinase (<l nmol . min-’ . mg-‘, measured in 
the absence or presence of 10 /.IM CAMP), phospho- 
rylase kinase (<l nmol min-’ mg-’ at pH 8.2) or 
phosphorylase phosphatase (<l pmol . min-’ . mg-‘, 
measured in the absence or presence of 1 mM free 
Mr?). 
The data in table 1 show that perfusion of rat hind- 
limb muscle with insulin (1 mu/ml) for 30 min results 
in changes in the glycogen synthase activity ratio (+5 
mM glucose-6-P) and A e.s for glucose-6-P which corre- 
spond to those reported for this system [9]. The lower 
Ao.S-values reported here are a result of Sephadex 
G-25 treatment of the extract before the Ao.s mea- 
surement. As indicated in table 1, the activity changes 
induced by the hormone are maintained throughout 
the enzyme purification*. 
The phosphate content of the purified glycogen 
synthase from the control groups was determined to 
be 3.4 +_ 0.1 mo1/85 000 g protein (table 2) based on 
the determinations from two enzyme purifications, 
each starting with pooled hindlimb muscle from 6-8 
rats. This is similar to the value reported in [5]. Per- 
fusion with insulin resulted in a reduction of the 
phosphate content to 2.7 ?r 0.2/85 000 g protein, again 
based on the determinations from 2 enzyme purifica- 
tions, each starting with muscle pooled from 6-8 rats. 
The change in the phosphorylation state is consistent 
with the changes seen in the activity ratio and the 
Ao,s for glucose-6-P (table 1). 
Perfusion with insulin also resulted in a reduction 
in the app. Km for UDPG, determined in the absence 
of glucose-6-P, for the purified enzymes (table 2). A 
similar difference could also be demonstrated in the 
muscle extract (not shown). Addition of 5 mM glu- 
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Table 1 
Procedure Total units Units/mg Yield (%) Activity ratio A,., Glc-6-P (mM) 
_____ (-Glc-6-P/+Glc-6-P) 
Saline Insulin Saline Insulin Saline Insulin Saline Insulin 
Saline Insulin 
Extract 131 140 0.03 0.03 100 100 0.13 0.18 0.09 0.06 
Acidification 82 71 0.11 0.11 63 51 0.12 0.15 
Glycogen pellet 80 71 0.16 0.13 61 51 0.10 0.16 
Supernatant (4000 X g) 57 56 0.31 0.25 44 40 0.11 0.15 
DEAE-Sepharose 9 I 19.5 9.20 7 5 0.11 0.18 0.09 0.06 
case-6-P resulted in similar app. Km-values for gly- 
cogen synthase purified from both the control and 
insulin-perfused tissues. 
4. Discussion 
Glycogen synthase from skeletal muscle normally 
exists in a partially phosphorylated state [3-61, as 
suggested from its activity characteristics (review 
[l-3]). Epinephrine increases the phosphate content 
as does the diabetic state [3,5,6]. These results show 
that in the rat hindlimb system, perfusion with insulin 
results in a reduction in the phosphate content, again 
consistent with reports on the activity characteristics 
of the enzyme [7-91. 
Insulin may promote glycogen synthesis in skeletal 
muscle both via increased glucose transport [ 161 and 
activation of glycogen synthase [7-91. The effects of 
insulin on these 2 systems appear to be separate [9] 
and the relative role of each in increasing glycogen 
synthesis remains to be delineated. For example, it is 
unclear how the facilitation of glucose transport 
induced by insulin in skeletal muscle increases gly- 
cogen synthesis, since there is no detectable concomi- 
tant increase in either glucose-6-P or UDPG [9]1 It 
also seems difficult to attribute the increase in glyco- 
gen to the small changes in the activity characteristics 
Table 2 
Treatment Mol phosphate/ Apparent Km UDPG 
85 000 g protein 
-Glc-6-P (mM) +Glc-6-P (PM) 
Saline 3.4 + 0.1 12.0 * 0.9 25.5 ? 0.3 
Insulin 2.7 c 0.2 7.8 + 0.4 25.0 * 0.1 
of glycogen synthase observed with the hormone [9]. 
These changes cannot be directly correlated with pos- 
sible physiological changes in the rate of glycogen 
synthesis because of the supraphysiological concen- 
trations of metabolites normally used in the assay of 
the enzyme. The above considerations indicate that a 
more detailed characterization of the properties of 
the enzyme needs to be done to understand the im- 
portance of the change in phosphate content promoted 
by insulin. 
These data show that in the absence of glucose-6-P, 
the enzymes prepared from insulinexposed and con- 
trol tissues exhibit different affinities for the substrate 
UDPG. The data also show that, in the presence of 
5 mM glucose-6-P, the substrate Km can be lowered 
to a concentration similar to that which exists in rat 
hindlimb muscle [9]. Km -Values similar to those of 
the purified enzymes, both in the presence and absence 
of glucose-6-P, were obtained when the activities pres- 
ent in the perfused tissues were measured in Sephadex 
G-25 filtrates (not shown). Although the enzymes 
from control and insulin-treated muscle exhibit simi- 
lar Km-values in the presence of saturating glucose- 
6-P, it is doubtful whether such conditions exist in 
the cell considering the presence of inhibitors [ 171 
and the concentration of glucose-6-P present [9]. A 
more detailed characterization of the differences in 
glycogen synthase activity promoted by insulin is 
being done. 
References 
111 
121 
[31 
Soderling, T. R. (1979) Mol. Cell. Endocrinol. 16, 
157-179. 
Roach, P. J. and Lamer, J. (1977) Mol. Cell. Biocliem. 
15,179-200. 
Cohen, P. (1978) Curr. Top. Cell. Regul. 14,117-196. 
187 
Volume 134, number 2 FEBS LETTERS November 1981 
[4] Roach, P. J., Rose&Perez, M. and Lamer, J. (1977) 
FEBS Lett. 80, 95-98. 
[5] Chiasson, J.-L., Aylward, J. H., Shikama, H. and Exton, 
J. H. (1981) FEBS Lett. 127, 97-100. 
[6] Sheorain, V. S., Khatra, B. S. and Soderling, T. R. 
(1981) FEBS Lett. 127,94-96. 
[7] Goldberg, N. D., Villar-Palasi, C., Sasko, H. and Larner, 
J. (1967) Biochim. Biophys. Acta 148,665-672. 
[S] Le Marchand-Brustel, Y. and Frey&et, P. (1979) J. 
Clin. Invest. 64, 1505-1515. 
[9] Chiasson, J.-L., Dietz, M. R., Shikama, H., Wootten, M. 
and Exton, J. H. (1980) Am. J. Physiol. 239, E69-E74. 
[lo] Caldwell, M. D., Lacy, W. W. and Exton, J. H. (1978) J. 
Biol. Chem. 253.6837-6844. 
[ 111 Thomas, J. A., S&lender, K. K. and Larner, J. (1968) 
Anal. Biochem. 25,486-499. 
[ 121 Lowry, 0. H., Rosebrough, N. J., Farr, A. L. and 
Randall, R. J. (1951) J. Biol. Chem. 193, 265-275. 
[13] Penney, C. L. (1976) Anal. Biochem. 75,201-210. 
[ 141 Weber, K. and Osborne, M. (1969) J. Biol. Chem. 244, 
4406-4412. 
[ 151 Soderling, T. R., Hickenbottom, J. P., Reimann, E. M., 
Hunkeler, F. L., Walsh, D. A. and Krebs, E. G. (1970) 
J. Biol. Chem. 245, 6317-6328. 
[ 161 Park, C. R., Reinwein, D., Henderson, M. J., Cadenas, 
E. and Morgan, H. E. (1959) Am. J. Med. 26,674-684. 
[ 171 Roach, P. J. and Lamer, J. (1976) J. Biol. Chem. 251, 
1920-1925. 
188 
